Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus-2), cause of COVID-19 (Coronavirus Disease of 2019), represents a significant risk to people living with pre-existing conditions associated with exacerbated inflammatory responses and consequent dysfunctional immunity. In this paper, we have...
Saved in:
| Main Authors: | Daniela Frasca, Lisa Reidy, Carolyn Cray, Alain Diaz, Maria Romero, Kristin Kahl, Bonnie B Blomberg |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0245424 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01) -
Stability of SARS-CoV-2 antibody in serum under various usage and storage conditions
by: Demet Hacıseyitoğlu, et al.
Published: (2024-09-01) -
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients
by: Eva Ulla Lorentzen, et al.
Published: (2025-05-01) -
Equine Hyperimmune Serum against the Inactivated SARS-CoV-2 Has Antibodies Neutralizing Titers
by: Neida Lucia Conrad, et al.
Published: (2025-07-01) -
SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)